Chronic Liver Disease and Cirrhosis
16
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (16)
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
Impact of Liver Transplantation on Sexual Life and Function
hepatomiR cACLD Study
Role of Exercise in Chronic Liver Disease Patients Undergoing Liver Transplantation
Impact of Home-Based Aerobic and Resistance Training in Chronic Liver Disease: a Randomized Control Trial
Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients
Non-invasive Methods for Predicting Decompensation of Chronic Liver Disease
Real-World Validation of a Prognostic Prediction Model for Patients With Acute Exacerbations of Chronic Liver Disease
Different Regimens of Vitamin D in Treatment of Children With Chronic Liver Disease
No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet Electrodes
Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care
Effectiveness of Nurse-led Physical Therapy in Terms of Patient Competency, Patient Engagement and Physical Performance.
Shear-wave Elastography Diffuse Liver Disease
Assessment of the Correlation Between Serum Levels of Adropin and Degree of Severity of Chronic Liver Disease
Invasive Fungal Infections in Severe Alcohol-associated Hepatitis
Immunological Measurement of Aspartate/Alanine Aminotransferase